AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-5.2%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(-2.2%)
Cap. Flow
+$6.06M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
256
New
24
Increased
39
Reduced
132
Closed
21
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
$3.22M |
| 2 |
uniQure
QURE
|
$2.31M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$2.18M |
| 4 |
TSVT
2seventy bio
TSVT
|
$1.87M |
| 5 |
Embecta
EMBC
|
$1.71M |
Top Sells
| 1 |
AdaptHealth
AHCO
|
$3.44M |
| 2 |
Elanco Animal Health
ELAN
|
$2.97M |
| 3 |
Centene
CNC
|
$2.7M |
| 4 |
iShares MBS ETF
MBB
|
$2.05M |
| 5 |
Lantheus
LNTH
|
$1.93M |
Sector Composition
| 1 | Healthcare | 61.76% |
| 2 | Real Estate | 10.3% |
| 3 | Financials | 3.56% |
| 4 | Technology | 3.07% |
| 5 | Energy | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
26
MFA Financial
MFA
$1.05B
| $1.95M | 1.1% |
202,725
+15,000
| +8% | +$144K |
|
27
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $1.91M | 1.08% |
110,000
| – | – |
|
28
GSK
GSK
$79.9B
| $1.81M | 1.03% |
50,000
| – | – |
|
|
NYMT
29
New York Mortgage Trust
NYMT
$652M
| $1.71M | 0.97% |
200,963
+15,000
| +8% | +$127K |
|
|
DCPH
30
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.68M | 0.95% |
132,000
+54,500
| +70% | +$693K |
|
31
Mr. Cooper
COOP
$12.1B
| $1.68M | 0.95% |
31,290
-10,000
| -24% | -$536K |
|
32
Phathom Pharmaceuticals
PHAT
$864M
| $1.66M | 0.94% |
160,000
+30,000
| +23% | +$311K |
|
33
Dynavax Technologies
DVAX
$1.19B
| $1.62M | 0.92% |
110,000
| – | – |
|
34
Amicus Therapeutics
FOLD
$2.34B
| $1.61M | 0.91% |
132,500
| – | – |
|
35
Karyopharm Therapeutics
KPTI
$61.7M
| $1.51M | 0.85% |
1,125,000
+315,000
| +39% | +$422K |
|
36
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.46M | 0.83% |
16,500
| – | – |
|
37
Immunovant
IMVT
$2.56B
| $1.46M | 0.83% |
+38,000
| New | +$1.46M |
|
38
argenx
ARGX
$43.6B
| $1.35M | 0.77% |
2,750
+500
| +22% | +$246K |
|
|
ITCI
39
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.33M | 0.75% |
25,500
| – | – |
|
40
MGIC Investment
MTG
$6.42B
| $1.32M | 0.75% |
79,379
-34,521
| -30% | -$576K |
|
41
Equity Lifestyle Properties
ELS
$11.7B
| $1.31M | 0.74% |
20,611
+12,500
| +154% | +$796K |
|
42
KalVista Pharmaceuticals
KALV
$678M
| $1.3M | 0.74% |
135,000
| – | – |
|
|
MOR
43
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.24M | 0.71% |
185,000
| – | – |
|
44
Viridian Therapeutics
VRDN
$1.5B
| $1.23M | 0.7% |
80,000
+44,500
| +125% | +$683K |
|
45
Verastem
VSTM
$569M
| $1.22M | 0.69% |
150,000
| – | – |
|
46
Alkermes
ALKS
$4.78B
| $1.19M | 0.68% |
42,500
+7,500
| +21% | +$210K |
|
|
BCYC
47
Bicycle Therapeutics
BCYC
$511M
| $1.18M | 0.67% |
+58,500
| New | +$1.18M |
|
48
Day One Biopharmaceuticals
DAWN
$769M
| $1.17M | 0.66% |
95,000
-15,000
| -14% | -$184K |
|
|
MITT
49
AG Mortgage Investment Trust
MITT
$240M
| $1.16M | 0.66% |
208,879
+104,058
| +99% | +$578K |
|
50
Enact Holdings
ACT
$5.55B
| $1.15M | 0.65% |
42,367
| – | – |
|